A Philadelphia startup that developed a 3D bioprinter business to produce lifelike tissue to support medical research has had quite a few changes in just the past few months. It rebranded from BioBots to Allevi as it rolled out new software to make the use of its bioprinter less time-consuming for academic researchers.3D bioprinting artists formerly known as BioBots add new software to streamline research needs
A Philadelphia startup that developed a 3D bioprinter business to produce lifelike tissue to support medical research has had quite a few changes in just the past few months. It rebranded from BioBots to Allevi as it rolled out new software to make the use of its bioprinter less time-consuming for academic researchers.
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon